A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 3 Active Dose Regimens of MORF-057 in Adults With Moderately to Severely Active Crohn's Disease (GARNET)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 3 Active Dose Regimens of MORF-057 in Adults With Moderately to Severely Active Crohn's Disease (GARNET)
This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 3 active dose regimens of MORF-057 in adult study participants with moderately to severely active Crohn's disease (CD).
This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of induction therapy with 3 active dose regimens of MORF-057 versus matching placebo in adult study participants with moderately to severely active CD. After completion of the 14-week Induction Period, all participants will receive open-label MORF-057 during the 38-week Maintenance Period. All participants who complete the full 52-week Treatment Period will also have the opportunity to continue treatment in a 52-week Long-Term Extension.
Key Inclusion Criteria:
Key Exclusion Criteria:
LillyTrials@Lilly.com1-317-615-4559
clinical_inquiry_hub@lilly.com
Lancaster, California 93534, United States
661-529-7550
Colorado Springs, Colorado 80921, United States
Atlanta, Georgia 30342, United States
Summerville, South Carolina 29486, United States
Johnson City, Tennessee 44060, United States
Houston, Texas 77030, United States
Woolloongabba, QLD, 4102, Australia
Banja Luka, 78000, Bosnia and Herzegovina
Zenica, 72000, Bosnia and Herzegovina
Campinas, 13093-133, Brazil
Alberta, T4P 1K4, Canada
Chicoutimi, G7H 5H6, Canada
Lethbridge, T1J 4G9, Canada
Tbilisi, 0178, Georgia
Munich, 81377, Germany
Békéscsaba, 5600, Hungary
Bhubaneswar, 751003, India
Rozzano, 20089, Italy
Turin, 10126, Italy
Kashiwa-shi, 277-0871, Japan
81120023812
Saitama-Ken, 350 8550, Japan
81120023812
Almaty, 050000, Kazakhstan
Mexico City, Distrito Federal, 06100, Mexico
Chisinau, MD-2025, Moldova
Chisinau, MD-2025, Moldova
Bydgoszcz, 85-794, Poland
Katowice, 40-748, Poland
Poznan, 60-309, Poland
Kaohsiung City, 807377, Taiwan
719-362-2266
407-846-6331
833-489-4968
407-241-1726
754-946-4172
404-257-9000
918-880-0676
920-437-5130
336-883-9773
336-613-6908
843-376-0670
423-208-9073
817-907-7330
903-630-6211
+61 (8) 8204 4964
+61 (7) 3646 4273
+61 (03) 9076 8838
+61 (3) 92313580
+61 (0) -8645-7367
61731767792
+43 (512) 504 23539
+43 (2742) 9004 12311
+43 (1) 40400 62450
+387 (51) 342 100
+55 (19) 98122-4244
+55 (11) 99245-2102
+359 (89) 980 5965
+359 (878) 304 281
+902 (473) 1499
+519 (685) 8500
+57 (6) 731 3737
+57 (7) 639 9658
+57 (604) 576 7272
57 (4) 445 9963
+57 (575) 371 5510
+385 (99) 834 3552
+ (385) 915881571
+ (420) 724 101 038
+ (420) 973 445 520
+420 () 222 962 476
+ (420) 776767590
+372 () 5326 9290
+372 () 651 1471
+372 () 731 8634
+33 () 4 78 86 12 89
+33 (3) 83153 631
+995 (593) 646 438
+995 (595) 527 222
+995 (577) 415 937
+995 (599) 585 864
+995 (593) 338 379
+995 (593) 283 528
+49 (30) 450 514102
49 (152) 0157 3335
+49 (08131) 61 190
+49 (203) 733 2385
+49 (069) 95332201
+49 (345) 557 2665
+49 (6221) 563 8865
+49 (431) 500 22202
+49 (341) 712 226
+49 (2267) 9201
+36 (66) 441 411
+36 (1) 459 1500
+36 (36) 411 444
+36 (37) 312 491
+36 (74) 501 872
+36 (22) 535 732
91 Q83298336) 22 433
+91 (6372) 900-010
+91 (4222) 327-17
+91 (9829) 050 622
9497556339
+91 (9891) 552 828
+91 (9766) 968 987
+91 (98242) 12 169
+91 (9825) 077-472
+91 (939) 107 5600
+39 (0961) 364 7111
+39 (026) 444 4454
+39 (02) 2643 2069
+39 (045) 601 4838
+39 () 0498215656
+39 (338) 736 7765
+39 (0882) 410 815
+00393476861126
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
+7 (747) 105-11-95
+7 (701) 884 4994
7 (701) 800 8621
+7 (701) 227-80-60
7 (778) 177-53-81
7 (701) 732-43-67
+7 (777) 502-99-55
+371 () 2925 3394
+52 (618) 197 3882
+373 (692) 63 789
+373 (79) 436 554
+373 (69) 010 553
78855508
+48 () 601667497
+48 () 533 550 245
+48 () 609 183 911
+0 (48) 538 935 600
+48 (58) 712 9970
+48 () 604 586 316
+48 () 797 947 052
+48 (12) 422 3271
+48 () 504 042 403
+48 (661) 160 410
+48 () 690 548 825
+48 () 698120205
+48 (61) 880 2994
+48 () 501011879
+48 (91) 433 2919
+48 (501) 464 891
+48 (22) 644 4161
+ (48) 575 000 489
+48 (60) 443 5392
+48 (22) 815 7384
+48 (71) 772 6000
+ (48) 604 911 743
+40 (732) 806 599
+40 (2) 1315 2590
+40 (767) 152 254
+381 (11) 381 0390
+0 (381) 637700043
+381 (64) 015 0022
+381 (64) 21023733
381 (60) 513 5299
+381 (060) 607 6527
+421 () 917 752 297
+421 () 905 271 215
+421 () 903 607 349
+421 () 905 794 001
+34 (91) 727 7264
+34 () 911916453
+34 (95) 500 8801
+34 (961) 973 118
+886 (5) 276 5041
886 7 312 1101
+886 (7) 342 2121
+886 (2) 77281704
+886 (4) 22052121
+886 (423) 592 525
+886 (6) 243 3407
+886 (2) 23123456 +886 (9) 726
+886 (6) 6655-1256
+886 (03) 328 1200